XML 35 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Equity - USD ($)
shares in Thousands, $ in Thousands
Cross Currency Interest Rate Contract [Member]
Common Stock [Member]
Cross Currency Interest Rate Contract [Member]
Additional Paid-in Capital [Member]
Cross Currency Interest Rate Contract [Member]
Treasury Stock, Common [Member]
Cross Currency Interest Rate Contract [Member]
Retained Earnings [Member]
Cross Currency Interest Rate Contract [Member]
AOCI Attributable to Parent [Member]
Cross Currency Interest Rate Contract [Member]
Parent [Member]
Cross Currency Interest Rate Contract [Member]
Noncontrolling Interest [Member]
Cross Currency Interest Rate Contract [Member]
Common Stock Outstanding [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock, Common [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Parent [Member]
Noncontrolling Interest [Member]
Total
Balance (in shares) at Dec. 31, 2020                 55,983                
Balance in Other comprehensive income (loss) beginning of period at Dec. 31, 2020                   $ 56 $ 1,262,446 $ 0 $ 550,103 $ (6,620) $ 1,805,985 $ 135,452 $ 1,941,437
Stock-based compensation                   0 9,168 0 0 0 9,168 0 9,168
Exercise of options by employees and directors (*) (in shares)                 73                
Exercise of options by employees and directors (*)                   0 0 0 0 0 0 0 0
Cash paid to noncontrolling interest                   0 0 0 0 0 0 (5,507) (5,507)
Cash dividend declared                   0 0 0 (26,986) 0 (26,986) 0 (26,986)
Stock issuance costs reimbursement                   0 311 0 0 0 311 0 311
Increase in noncontrolling interest                   0 0 0 0 0 0 1,357 1,357
Net income                   0 0 0 62,092 0 62,092 13,366 75,458
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax                   0 0 0 0 (2,030) (2,030) (1,206) (3,236)
Change in unrealized gains or losses in respect of the Company's share in derivative instruments of unconsolidated investment that qualifies as a cash flow hedge                   0 0 0 0 3,892 3,892 0 3,892
Change in respect of derivative instruments designated for cash flow hedge $ 0 $ 0 $ 0 $ 0 $ 2,379 $ 2,379 $ 0 $ 2,379                 2,379
Change in unrealized gains or losses on marketable securities available-for-sale (net of related tax)                   0 0 0 0 (40) (40) 0 (40)
Other                   0 0 0 0 228 228 0 228
Issuance of common stock                   0 311 0 0 0 311 0 311
Net income                   0 0 0 62,092 0 62,092 13,366 75,458
Change in unrealized gains or losses in respect of a cross currency swap derivative instrument that qualifies as a cash flow hedge (net of related tax of $1,511 and $464, respectively) 0 0 0 0 2,379 2,379 0 2,379                 2,379
Balance (in shares) at Dec. 31, 2021                 56,056                
Balance in Other comprehensive income (loss) end of period at Dec. 31, 2021                   56 1,271,925 0 585,209 (2,191) 1,854,999 143,462 1,998,461
Stock-based compensation                   0 11,646 0 0 0 11,646 0 11,646
Exercise of options by employees and directors (*) (in shares)                 299                
Exercise of options by employees and directors (*)                   0 39 0 0 0 39 0 39
Cash paid to noncontrolling interest                   0 0 0 0 0 0 (4,811) (4,811)
Cash dividend declared                   0 0 0 (27,143) 0 (27,143) 0 (27,143)
Increase in noncontrolling interest                   0 0 0 0 0 0 3,970 3,970
Net income                   0 0 0 65,841 0 65,841 11,316 77,157
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax                   0 0 0 0 (1,953) (1,953) (533) (2,486)
Change in unrealized gains or losses in respect of the Company's share in derivative instruments of unconsolidated investment that qualifies as a cash flow hedge                   0 0 0 0 8,370 8,370 0 8,370
Change in respect of derivative instruments designated for cash flow hedge 0 0 0 0 (1,825) (1,825) 0 (1,825)                 (1,825)
Change in unrealized gains or losses on marketable securities available-for-sale (net of related tax)                   0 0 0 0 40 40 0 40
Other                   0 0 0 0 59 59 0 59
Purchase of treasury stock (in shares)                 (259)                
Purchase of treasury stock                   0 0 (17,964) 0 0 (17,964) 0 (17,964)
Purchase of capped call transactions                   0 (24,538) 0 0 0 (24,538) 0 (24,538)
Net income                   0 0 0 65,841 0 65,841 11,316 77,157
Change in unrealized gains or losses in respect of a cross currency swap derivative instrument that qualifies as a cash flow hedge (net of related tax of $1,511 and $464, respectively) $ 0 $ 0 $ 0 $ 0 $ (1,825) $ (1,825) $ 0 $ (1,825)                 (1,825)
Balance (in shares) at Dec. 31, 2022                 56,096                
Balance in Other comprehensive income (loss) end of period at Dec. 31, 2022                   56 1,259,072 (17,964) 623,907 2,500 1,867,571 153,404 2,020,975
Stock-based compensation                   0 15,478 0 0 0 15,478 0 15,478
Exercise of options by employees and directors (*) (in shares) [1]                 123                
Exercise of options by employees and directors (*) [1]                   0 314 0 0 0 314 0 314
Cash paid to noncontrolling interest                   0 0 0 0 0 0 (7,648) (7,648)
Cash dividend declared                   0 0 0 (28,412) 0 (28,412) 0 (28,412)
Stock issuance costs reimbursement                   4 341,667 0 0 0 341,671 0 341,671
Net income                   0 0 0 124,399 0 124,399 7,799 132,198
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax                   0 0 0 0 822 822 435 1,257
Change in unrealized gains or losses in respect of the Company's share in derivative instruments of unconsolidated investment that qualifies as a cash flow hedge                   0 0 0 0 (470) (470) 0 (470)
Change in respect of derivative instruments designated for cash flow hedge                   0 0 0 0 (4,237) (4,237) 0 (4,237)
Change in unrealized gains or losses on marketable securities available-for-sale (net of related tax)                                 0
Other                   0 0 0 0 53 53 0 53
Issuance of common stock (in shares)                 4,140                
Issuance of common stock                   4 341,667 0 0 0 341,671 0 341,671
Change in noncontrolling interest rights (net if related tax of $338)                   0 901 0 0 0 901 (2,038) (1,137)
Transaction with noncontrolling interest                   0 (2,663) 0 0 0 (2,663) (26,392) (29,055)
Net income                   0 0 0 124,399 0 124,399 7,799 132,198
Change in unrealized gains or losses in respect of a cross currency swap derivative instrument that qualifies as a cash flow hedge (net of related tax of $1,511 and $464, respectively)                   0 0 0 0 (4,237) (4,237) 0 (4,237)
Balance (in shares) at Dec. 31, 2023                 60,359                
Balance in Other comprehensive income (loss) end of period at Dec. 31, 2023                   $ 60 $ 1,614,769 $ (17,964) $ 719,894 $ (1,332) $ 2,315,427 $ 125,560 $ 2,440,987
[1] Resulted in an amount lower than $1 thousand.